Treatment of hepatocellular carcinoma with autologous platelets encapsulating sorafenib or lenvatinib: A novel therapy exploiting tumor‐platelet interactions-Reference-Cited by-同舟云学术

Treatment of hepatocellular carcinoma with autologous platelets encapsulating sorafenib or lenvatinib: A novel therapy exploiting tumor‐platelet interactions

Published:2021-12-29 Issue: Volume: Page:
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Tanaka Hiroki¹^ORCID,Horioka Kie²³,Hasebe Takumu⁴,Sawada Koji⁴,Nakajima Shunsuke⁵,Konishi Hiroaki⁶,Isozaki Shotaro⁴,Goto Masanori¹,Fujii Yumiko¹,Kamikokura Yuki¹,Ogawa Katsuhiro⁷,Nishikawa Yuji¹

Affiliation:

1. Division of Tumor Pathology, Department of Pathology Asahikawa Medical University Asahikawa Japan

2. Department of Oncology‐Pathology Karolinska Institutet Stockholm Sweden

3. Department of Legal Medicine International University of Health and Welfare Narita Japan

4. Division of Metabolism and Biosystemic Science, Gastroenterology and Hematology/Oncology, Department of Medicine Asahikawa Medical University Asahikawa Japan

5. Department of Emergency Medicine Asahikawa Medical University Asahikawa Japan

6. Department of Gastroenterology and Advanced Medical Sciences Asahikawa Medical University Asahikawa Japan

7. Asahikawa Medical University Asahikawa Japan

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33915

Reference39 articles.

1. Targeted Therapies for Hepatocellular Carcinoma

2. Hepatocellular Carcinoma

3. Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis

4. Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents

5. Tumor-platelet interaction in solid tumors

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The platelet-related genes associated with the prognosis of HCC by regulating cycling T cell and prolif-TAMs;Heliyon;2024-03

2. Cellular drug delivery system for disease treatment;International Journal of Pharmaceutics;2023-06

3. Platelets for advanced drug delivery in cancer;Expert Opinion on Drug Delivery;2023-05-04

4. Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin;Journal of Experimental & Clinical Cancer Research;2022-09-07